• 出版社/出版日：Mordor Intelligence / 2019年12月26日
|Single User||￥484,500 (USD4,250)||▷ お問い合わせ|
|Multi User||￥541,500 (USD4,750)||▷ お問い合わせ|
|Global Site License||￥855,000 (USD7,500)||▷ お問い合わせ|
Microfluidics Market – Growth, Trends, and Forecast (2019 – 2024)
The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD 13,348.29 million in 2024, witnessing a CAGR of 18.80%. Factors that are propelling the growth of the market include rising demand for point-of-care testing, increasing Incidences of chronic diseases, faster turn-around time for analysis, and improved portability of devices.
POC testing allows healthcare experts to diagnose a patient in the physician’s office, in an ambulance, at home, field, or in the hospital. Microfluidic technology-assisted devices are being employed for POC testing, as they require small volumes of samples and use micro-fabricated channels to analyze these samples. POC testing devices are already popular in glucose, blood, hemoglobin, and HIV testing domains. Future POC testing devices are likely to focus more on antibiotics therapies and cancer.
With the wide range of applications offered by these devices, microfluidic technology-based POC testing devices have immense potential in the developing and developed countries, as the percentage of population affected by these diseases is high.
Scope of the Report
This report estimates the global microfluidics market size by summing up the value of market segments divided on the basis of type of component, application, and materials. Further, each of these segments are sub-divided to cover all relevant categories.
Key Market Trends
Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment
In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.80% during the forecast period.
A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient’s blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.
So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market’s growth.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R&D. Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.
The microfluidics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with affordable prices. Companies, like Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., hold substantial shares in the market.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Point-of-care Testing
4.2.2 Increasing Incidences of Chronic Diseases
4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
4.3 Market Restraints
4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process
4.3.2 Low Adoption in Developing Countries due to High Prices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1.1 Microfluidic Chips
5.1.2 Micro Pumps
5.1.3 Micro Needles
5.1.4 Other Components
5.2.1 Drug Delivery
5.2.2 High-throughput Screening
5.2.3 Point-of-Care Diagnostics
5.2.4 Lab Analytics
220.127.116.11 Cell-based Assay
18.104.22.168 Capillary Electrophoresis
5.2.5 Clinical Diagnostics
5.4.1 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
5.4.4 Middle East & Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East & Africa
5.4.5 South America
126.96.36.199 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-LA Roche Ltd
6.1.3 Agilent Technologies
6.1.4 Danaher Corporation (Cepheid)
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 PerkinElmer Inc.
6.1.8 FluIdigm Corporation
6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd)
6.1.10 Micronit Microfluidics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS